Israeli PolyPid signs $320 million deal to sell drug preventing surgical infections in US, Canada
D-PLEX100 is designed to provide local, prolonged, and controlled antibacterial activity directly at the surgical site to prevent abdominal surgical site infections.
No comments yet. Be the first to add a perspective.